The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …

Scottish clinical stage biopharma firm Nucana has appointed Dr Martin Birkhofer as its chief medical officer. Birkhofer, an oncologist by training, …

Google has invested into a company that funds spinoffs from Oxford University’s technology and science departments called Oxford Sciences Innovation …

The FDA has expanded the patient groups for whom Eisai’s epilepsy drug Fycompa is available to include people who have …

Healthcare comms agency GCI Health has promoted Claire Martin to associate director and Laura Starr to associate director and head …

In recent months the focus on the need to develop new drugs and fund new treatments for rare diseases has …

Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …

Counterfeit and unlicensed medicines and devices worth £15.8 million have been seized in the UK as part of a global …

Health and fitness wearable device Fitbit has beaten expectations as the company’s shares soar following its first day of trading …

Investment banking boutique Zeus Capital is increasing its healthcare sector team by hiring Phil Walker to head the firm’s healthcare …

The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance. But the …
Sanofi and Merck are looking forward to a successor to their blockbuster Gardasil now that the European Commission has granted …

US president Barack Obama has no ‘Plan B’ if a crucial Supreme Court vote in the next fortnight goes against …

NHS England has laid out digital technology plans that it says will completely transform services and improve health outcomes using …

Pam Cheng has joined AstraZeneca from Merck to be its executive vice president of operations and IT. Cheng succeeds David …

GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …

UK late-stage biopharma firm Immodulon Therapeutics has made two new senior appointments to its board of directors. Investment fund manager …

Actavis has now officially changed its name to Allergan following the Ireland-based company’s recent acquisition of the botox maker. This …

Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …

The US Food and Drug Administration has signed a research deal with PatientsLikeMe in a move the online patient network …